| Year |
Citation |
Score |
| 2024 |
Hossain MM, King P, Hackett J, Gerard HC, Niwinski R, Wu L, Van Kaer L, Dyson G, Gibson H, Borowsky AD, Sebzda E. Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner. Proceedings of the National Academy of Sciences of the United States of America. 121: e2404916121. PMID 39207730 DOI: 10.1073/pnas.2404916121 |
0.335 |
|
| 2024 |
Borowsky A, Glencer A, Ramalingam K, Schindler N, Mori H, Ghule P, Lee K, Nachmanson D, Officer A, Harismendy O, Stein J, Stein G, Evans M, Weaver D, Yau C, et al. Tumor microenvironmental determinants of high-risk DCIS progression. Research Square. PMID 38766192 DOI: 10.21203/rs.3.rs-4126092/v1 |
0.329 |
|
| 2023 |
Tong JH, Elmore S, Huang SS, Tachachartvanich P, Manz K, Pennell K, Wilson MD, Borowsky A, La Merrill MA. Chronic Exposure to Low Levels of Parabens Increases Mammary Cancer Growth and Metastasis in Mice. Endocrinology. 164. PMID 36683225 DOI: 10.1210/endocr/bqad007 |
0.346 |
|
| 2022 |
Griessinger J, Schwab J, Chen Q, Kühn A, Cotton J, Bowden G, Preibsch H, Reischl G, Quintanilla-Martinez L, Mori H, Dang AN, Kohlhofer U, Aina OH, Borowsky AD, Pichler BJ, et al. Intratumoral in vivo staging of breast cancer by multi-tracer PET and advanced analysis. Npj Breast Cancer. 8: 41. PMID 35332139 DOI: 10.1038/s41523-022-00398-x |
0.3 |
|
| 2021 |
Ginzel JD, Acharya CR, Lubkov V, Mori H, Boone PG, Rochelle LK, Roberts W, Everitt JI, Hartman ZC, Crosby EJ, Barak LS, Caron MG, Chen JQ, Hubbard NE, Cardiff RD, ... Borowsky AD, et al. HER2 isoforms uniquely program intratumor heterogeneity and predetermine breast cancer trajectories during the occult tumorigenic phase. Molecular Cancer Research : McR. PMID 34131071 DOI: 10.1158/1541-7786.MCR-21-0215 |
0.384 |
|
| 2021 |
Vogel CFA, Lazennec G, Kado SY, Dahlem C, He Y, Castaneda A, Ishihara Y, Vogeley C, Rossi A, Haarmann-Stemmann T, Jugan J, Mori H, Borowsky AD, La Merrill MA, Sweeney C. Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development. Frontiers in Immunology. 12: 625346. PMID 33763068 DOI: 10.3389/fimmu.2021.625346 |
0.403 |
|
| 2020 |
Damaghi M, Mori H, Byrne S, Xu L, Chen T, Johnson J, Gallant ND, Marusyk A, Borowsky AD, Gillies RJ. Collagen production and niche engineering: A novel strategy for cancer cells to survive acidosis in DCIS and evolve. Evolutionary Applications. 13: 2689-2703. PMID 33294017 DOI: 10.1111/Eva.13075 |
0.396 |
|
| 2020 |
Esserman LJ, Hewitt K, Son J, Glencer A, Borowsky AD, Cooperberg MR. The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33033145 DOI: 10.1158/1055-9965.EPI-20-0110 |
0.323 |
|
| 2020 |
Bacorn C, Kim E, Borowsky AD, Lin LK. Previously undiagnosed neuroendocrine tumour mimicking breast cancer metastasis to the orbit. Bmj Case Reports. 13. PMID 32439746 DOI: 10.1136/Bcr-2020-234629 |
0.381 |
|
| 2020 |
Siddiqui S, Libertini SJ, Lucas CA, Lombard AP, Baek HB, Nakagawa RM, Nishida KS, Steele TM, Melgoza FU, Borowsky AD, Durbin-Johnson BP, Qi L, Ghosh PM, Mudryj M. The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells. Cancer Letters. PMID 32330514 DOI: 10.1016/J.Canlet.2020.03.030 |
0.371 |
|
| 2020 |
Moon H, White AC, Borowsky AD. New insights into the functions of Cox-2 in skin and esophageal malignancies. Experimental & Molecular Medicine. PMID 32235869 DOI: 10.1038/S12276-020-0412-2 |
0.422 |
|
| 2020 |
McNamara G, Lucas J, Beeler JF, Basavanhally A, Lee G, Hedvat CV, Baxi VA, Locke D, Borowsky A, Levenson R. New Technologies to Image Tumors. Cancer Treatment and Research. 180: 51-94. PMID 32215866 DOI: 10.1007/978-3-030-38862-1_2 |
0.389 |
|
| 2020 |
Ishikawa T, Tong J, Borowsky A, Cardiff R, Merrill ML. Abstract A48: Perinatal DDT exposure shortens latency of mouse mammary tumorigenesis Cancer Prevention Research. 13. DOI: 10.1158/1940-6215.Envcaprev19-A48 |
0.411 |
|
| 2020 |
Dempsey A, Yau C, Harismendy O, Donnenfield J, Basu A, Campbell M, Borowsky AD, Hirst G, Esserman LJ. Abstract P6-06-07: Gene expression changes in the epithelium and stroma of invasive ductal carcinoma and ductal carcinoma in situ: A meta-analysis Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P6-06-07 |
0.368 |
|
| 2020 |
Huilgol YS, Keane H, Shieh Y, Tice J, Ziv E, Madlensky L, Sabacan L, Acerbi I, Che M, Fiscalini AS, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker B, et al. Abstract P5-08-01: Breast cancer risk thresholds as a predictor of chemoprevention uptake in the Athena Breast Health Network Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-08-01 |
0.347 |
|
| 2020 |
Fereidouni F, Borowsky AD, Levenson RM. Abstract P5-02-13: A novel detection technique for collagen (and other macromolecules) on H&E slides without special stains for improved cancer prognostics Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-02-13 |
0.397 |
|
| 2020 |
Wei JM, Kim P, Ewing C, Wong J, Esserman LJ, Alvarado MD, Olusanya AO, Stewart S, Tydon A, Daroui P, Kuo JV, Park HL, Lane KT, Jeong E, Brown K, ... ... Borowsky AD, et al. Abstract OT3-09-01: Use of Oncotype DX DCIS for disease management in a prospective DCIS registry Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Ot3-09-01 |
0.361 |
|
| 2020 |
Che M, Fiscallini AS, Acerbi I, Shieh Y, Madlensky L, Tice J, Ziv E, Eklund M, Blanco A, Tong B, Goodman D, Nassereddine L, Anderson N, Harvey H, Fors S, ... ... Borowsky A, et al. Abstract OT3-03-02: Personalized breast cancer screening in a population-based study: Women informed to screen depending on measures of risk (WISDOM) Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Ot3-03-02 |
0.359 |
|
| 2020 |
Glencer A, Harismendy O, Borowsky A, Hirst GL, Stein J, Evans M, Weaver D, West R, Brabham C, Mori H, Esserman LJ. Abstract 5440: Understanding the biology of high-risk ductal carcinoma in situ (DCIS) through genomics and the tumor immune microenvironment: The DEFENSE study Cancer Research. 80: 5440-5440. DOI: 10.1158/1538-7445.Am2020-5440 |
0.46 |
|
| 2019 |
Boone PG, Rochelle LK, Ginzel JD, Lubkov V, Roberts WL, Nicholls PJ, Bock C, Flowers ML, von Furstenberg RJ, Stripp BR, Agarwal P, Borowsky AD, Cardiff RD, Barak LS, Caron MG, et al. A cancer rainbow mouse for visualizing the functional genomics of oncogenic clonal expansion. Nature Communications. 10: 5490. PMID 31792216 DOI: 10.1038/S41467-019-13330-Y |
0.347 |
|
| 2019 |
Cai D, Wang J, Gao B, Li J, Wu F, Zou JX, Xu J, Jiang Y, Zou H, Huang Z, Borowsky AD, Bold RJ, Lara PN, Li JJ, Chen X, et al. RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. Nature Communications. 10: 4621. PMID 31604910 DOI: 10.1038/S41467-019-12529-3 |
0.385 |
|
| 2019 |
Tucci ST, Kheirolomoom A, Ingham ES, Mahakian LM, Tam SM, Foiret J, Hubbard NE, Borowsky AD, Baikoghli M, Cheng RH, Ferrara KW. Tumor-specific delivery of gemcitabine with activatable liposomes. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31301340 DOI: 10.1016/J.Jconrel.2019.07.014 |
0.412 |
|
| 2019 |
Srivastava S, Koay EJ, Borowsky AD, De Marzo AM, Ghosh S, Wagner PD, Kramer BS. Cancer overdiagnosis: a biological challenge and clinical dilemma. Nature Reviews. Cancer. PMID 31024081 DOI: 10.1038/S41568-019-0142-8 |
0.362 |
|
| 2019 |
Kheirolomoom A, Silvestrini MT, Ingham ES, Mahakian LM, Tam SM, Tumbale SK, Foiret J, Hubbard NE, Borowsky AD, Ferrara KW. Combining activatable nanodelivery with immunotherapy in a murine breast cancer model. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30978432 DOI: 10.1016/J.Jconrel.2019.04.008 |
0.423 |
|
| 2019 |
Pénzváltó Z, Chen JQ, Tepper CG, Davis RR, Silvestrini MT, Umeh-Garcia M, Sweeney C, Borowsky AD. A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials. Journal of Mammary Gland Biology and Neoplasia. PMID 30810966 DOI: 10.1007/S10911-019-09425-3 |
0.406 |
|
| 2019 |
Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, et al. A response to "Personalised medicine and population health: breast and ovarian cancer". Human Genetics. PMID 30810870 DOI: 10.1007/S00439-019-01984-Z |
0.337 |
|
| 2019 |
Penzvalto Z, Chen J, Cardiff R, Willis B, Hubbard N, Piersigilli A, Borowsky A. Abstract P6-03-03: Withdrawn Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P6-03-03 |
0.351 |
|
| 2019 |
Acerbi I, Shieh Y, Madlensky L, Tice J, Ziv E, Eklund M, Blanco A, DeRosa D, Tong B, Goodman D, Nassereddine L, Anderson N, Harvey H, Layton T, Park H, ... ... Borowsky A, et al. Abstract OT2-08-01: Personalized breast cancer screening in a population based study: Women Informed to Screen Depending On Measures of risk (WISDOM) Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Ot2-08-01 |
0.324 |
|
| 2019 |
Kheirolomoom A, Silvestrini MT, Ingham ES, Mahakian LM, Tam SM, Tumbale SK, Foiret J, Hubbard NE, Borowsky AD, Murphy WJ, Ferrara KW. Abstract 3952: Localized nanodelivery combined with immunotherapy promotes curative anti-tumor responses in a murine breast cancer model Cancer Research. 79: 3952-3952. DOI: 10.1158/1538-7445.Am2019-3952 |
0.456 |
|
| 2019 |
Tucci ST, Kheirolomoom A, Ingham ES, Mahakian LM, Tam SM, Foiret J, Hubbard NE, Borowsky AD, Baikoghli M, Cheng RH, Ferrara KW. Abstract 2171: Activatable nanodelivery of high payload gemcitabine augments therapeutic efficacy in murine breast and pancreatic cancer models Cancer Research. 79: 2171-2171. DOI: 10.1158/1538-7445.Am2019-2171 |
0.407 |
|
| 2018 |
Chavez M, Silvestrini MT, Ingham ES, Fite BZ, Mahakian LM, Tam SM, Ilovitsh A, Monjazeb AM, Murphy WJ, Hubbard NE, Davis RR, Tepper CG, Borowsky AD, Ferrara KW. Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation. Theranostics. 8: 3611-3628. PMID 30026870 DOI: 10.7150/Thno.25613 |
0.358 |
|
| 2018 |
Seo JW, Tavaré R, Mahakian LM, Silvestrini MT, Tam S, Ingham ES, Salazar FB, Borowsky AD, Wu AM, Ferrara KW. CD8+ T-cell density imaging with 64Cu-labeled cys-diabody informs immunotherapy protocols. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29967252 DOI: 10.1158/1078-0432.Ccr-18-0261 |
0.33 |
|
| 2018 |
Pelissier Vatter FA, Schapiro D, Chang H, Borowsky AD, Lee JK, Parvin B, Stampfer MR, LaBarge MA, Bodenmiller B, Lorens JB. High-Dimensional Phenotyping Identifies Age-Emergent Cells in Human Mammary Epithelia. Cell Reports. 23: 1205-1219. PMID 29694896 DOI: 10.1016/J.Celrep.2018.03.114 |
0.369 |
|
| 2018 |
Mori H, Cardiff RD, Borowsky AD. Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression. Frontiers in Cell and Developmental Biology. 6: 35. PMID 29651417 DOI: 10.3389/Fcell.2018.00035 |
0.484 |
|
| 2018 |
Gonzalez VD, Samusik N, Chen TJ, Savig ES, Aghaeepour N, Quigley DA, Huang YW, Giangarrà V, Borowsky AD, Hubbard NE, Chen SY, Han G, Ashworth A, Kipps TJ, Berek JS, et al. Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry. Cell Reports. 22: 1875-1888. PMID 29444438 DOI: 10.1016/J.Celrep.2018.01.053 |
0.426 |
|
| 2018 |
Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, ... ... Borowsky AD, et al. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. Journal of the National Cancer Institute. PMID 29361175 DOI: 10.1093/Jnci/Djx270 |
0.374 |
|
| 2018 |
Rowson-Hodel AR, Wald JH, Hatakeyama J, O'Neal WK, Stonebraker JR, VanderVorst K, Saldana MJ, Borowsky AD, Sweeney C, Carraway KL. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer. Oncogene. 37: 197-207. PMID 28892049 DOI: 10.1038/Onc.2017.327 |
0.453 |
|
| 2018 |
Campbell M, Yau C, Borowsky A, Vandenberg S, Wolf D, Rimm D, Nanda R, Liu M, Brown-Swigart L, Hirst G, Asare S, Veer Lv, Yee D, DeMichele A, Berry D, et al. Abstract PD6-08: Analysis of immune infiltrates (assessed via multiplex fluorescence immunohistochemistry) and immune gene expression signatures as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 trial Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd6-08 |
0.385 |
|
| 2018 |
Naeim A, Sepucha K, Wenger N, Eklund M, Annette S, Madlensky L, Veer Lv, Parker B, Yau C, Cink T, Anton-Culver H, Borowsky A, Petruse A, Sarrafan S, Stover-Fiscalini A, et al. Abstract PD2-14: Participation in a personalized breast cancer screening trial does not increase anxiety at baseline Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd2-14 |
0.369 |
|
| 2018 |
Acerbi I, Abihider K, Layton T, DeRosa D, Madlensky L, Tice J, Shieh Y, Ziv E, Sarrafan S, Firouzian R, Tong B, Blanco A, Lee V, Heditsian D, Brain S, ... ... Borowsky A, et al. Abstract OT3-03-01: Preference-Tolerant randomized trial of risk-based vs. annual breast cancer screening: WISDOM study in progress Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Ot3-03-01 |
0.368 |
|
| 2017 |
Mori H, Chen JQ, Cardiff RD, Pénzváltó Z, Hubbard NE, Schuetter L, Hovey RC, Trott JF, Borowsky AD. Pathobiology of the 129:Stat1 (-/-) mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype. Breast Cancer Research : Bcr. 19: 102. PMID 28865492 DOI: 10.1186/S13058-017-0892-8 |
0.448 |
|
| 2017 |
Esserman LJ, Yau C, Thompson CK, van 't Veer LJ, Borowsky AD, Hoadley KA, Tobin NP, Nordenskjöld B, Fornander T, Stål O, Benz CC, Lindström LS. Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades. Jama Oncology. PMID 28662222 DOI: 10.1001/Jamaoncol.2017.1261 |
0.411 |
|
| 2017 |
Fite BZ, Kheirolomoom A, Foiret JL, Seo JW, Mahakian LM, Ingham ES, Tam SM, Borowsky AD, Curry FE, Ferrara KW. Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28395970 DOI: 10.1016/J.Jconrel.2017.04.007 |
0.331 |
|
| 2017 |
Silvestrini MT, Ingham ES, Mahakian LM, Kheirolomoom A, Liu Y, Fite BZ, Tam SM, Tucci ST, Watson KD, Wong AW, Monjazeb AM, Hubbard NE, Murphy WJ, Borowsky AD, Ferrara KW. Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols. Jci Insight. 2: e90521. PMID 28352658 DOI: 10.1172/Jci.Insight.90521 |
0.395 |
|
| 2017 |
Esserman L, Yau C, Thompson C, Veer Lv, Borowsky A, Hoadley K, Tobin N, Nordenskjöld B, Fornander T, Stål O, Benz C, Lindström L. Abstract PD7-02: Identification of breast cancers with an indolent disease course: 70 gene indolent threshold validation in a Swedish randomized trial of tamoxifen vs. not, with 20 year outcomes Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-Pd7-02 |
0.452 |
|
| 2017 |
Fiscalini AS, Theiner S, Kaplan C, Sarrafan S, Sawyer S, Liang A, Rosenberg-Wohl S, Gordon D, Frick M, Borowsky A, Anton-Culver H, Naeim A, LaCroix A, Cink T, Partners A, et al. Abstract P5-02-03: Evaluating the feasibility of a web-based preference-tolerant randomized trial of risk-based vs. annual breast cancer screening: WISDOM study pilot Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-02-03 |
0.357 |
|
| 2017 |
Lindström L, Yau C, Czene K, Thompson C, Veer Lv, Nordenskjöld B, Stål O, Fornander T, Benz C, Borowsky A, Esserman L. Abstract P2-05-03: Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival – Retrospective analyses of the STO-3 randomized trial Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P2-05-03 |
0.465 |
|
| 2017 |
Silvestrini MT, Ingham ES, Mahakian LM, Kheirolomoom A, Liu Y, Fite BZ, Tam SM, Tucci S, Watson KD, Wong AW, Monjazeb AM, Hubbard NE, Murphy WJ, Borowsky AD, Ferrara KW. Abstract 576: Neoadjuvant immunotherapy improves efficacy of image-guided thermal ablation to generate curative responses in a murine breast cancer model Cancer Research. 77: 576-576. DOI: 10.1158/1538-7445.Am2017-576 |
0.41 |
|
| 2017 |
Kheirolomoom A, Silvestrini M, Mahakian L, Ingham E, Foiret J, Tumbale S, Tam S, Hubbard N, Borowsky A, Ferrara K. Abstract 4603: Protocol optimization combining activatable nanodelivery with immunotherapy in a murine breast cancer model Cancer Research. 77: 4603-4603. DOI: 10.1158/1538-7445.Am2017-4603 |
0.421 |
|
| 2017 |
Lechpammer M, Tian M, Shahlaie K, Fereidouni F, Harmany ZT, Borowsky AD, Zagzag D, Levenson RM. P03.14 Validation of microscopy with ultraviolet surface excitation - MUSE - imaging of human primary and metastatic brain tumors Neuro-Oncology. 19: iii36-iii36. DOI: 10.1093/Neuonc/Nox036.129 |
0.316 |
|
| 2017 |
Lindström LS, Yau C, Czene K, Thompson C, Yu N, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman L. 24OIncreased long-term risk of fatal breast cancer in patients with high intra-tumor heterogeneity of the estrogen receptor – Retrospective analyses of the STO-3 trial Annals of Oncology. 28. DOI: 10.1093/Annonc/Mdx138 |
0.411 |
|
| 2016 |
Sahasrabudhe R, Lott P, Bohorquez M, Toal T, Estrada AP, Suarez JJ, Brea-Fernández A, Cameselle-Teijeiro J, Pinto C, Ramos I, Mantilla A, Prieto R, Corvalan A, Norero E, Alvarez C, ... ... Borowsky A, et al. Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients with Gastric Cancer. Gastroenterology. PMID 28024868 DOI: 10.1053/J.Gastro.2016.12.010 |
0.303 |
|
| 2016 |
Lobo RC, Hubbard NE, Damonte P, Mori H, Pénzváltó Z, Pham C, Koehne AL, Go AC, Anderson SE, Cala PM, Borowsky AD. Glucose Uptake and Intracellular pH in a Mouse Model of Ductal Carcinoma In situ (DCIS) Suggests Metabolic Heterogeneity. Frontiers in Cell and Developmental Biology. 4: 93. PMID 27630987 DOI: 10.3389/Fcell.2016.00093 |
0.723 |
|
| 2016 |
Schmitz J, Schwab J, Schwenck J, Chen Q, Quintanilla-Martinez L, Hahn M, Wietek B, Schwenzer N, Staebler A, Kohlhofer U, Aina OH, Hubbard NE, Reischl G, Borowsky AD, Brucker S, et al. Decoding intratumoral heterogeneity of breast cancer by multiparametric in vivo imaging: A translational study. Cancer Research. PMID 27466286 DOI: 10.1158/0008-5472.Can-15-0642 |
0.431 |
|
| 2016 |
Wang J, Duan Z, Nugent Z, Zou JX, Borowsky AD, Zhang Y, Tepper CG, Li JJ, Fienh O, Xu J, Kung HJ, Murphy L, Chen HW. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes. Cancer Letters. PMID 27164560 DOI: 10.1016/J.Canlet.2016.05.004 |
0.386 |
|
| 2016 |
Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao AC, Evans CP, Lam KS, Xu J, Kung HJ, et al. ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nature Medicine. PMID 27019329 DOI: 10.1038/Nm.4070 |
0.367 |
|
| 2016 |
Borowsky A, Esserman L. When the Gold Standard Loses Its Luster, Perhaps It Is Time to Change Nomenclature Annals of Internal Medicine. 164: 694-695. PMID 26999728 DOI: 10.7326/M16-0526 |
0.358 |
|
| 2016 |
Goldstein J, Borowsky AD, Goyal R, Roland JT, Arnold S, Gellert LL, Clark PE, Hameed O, Giannico GA. Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (MAGI-2) in prostate cancer: an immunohistochemical study. Human Pathology. PMID 26980016 DOI: 10.1016/J.Humpath.2016.01.003 |
0.309 |
|
| 2016 |
Rosenberg-Wohl S, Eklund M, Tice J, Ziv E, Kaplan C, Van't Veer L, LaCroix A, Madlensky L, Naeim A, Wenger N, Borowsky AD, Fenton J, Anton-Culver H, Hogarth M, Cink T, et al. Women informed to screen depending on measures of risk (WISDOM): A RCT of personalized vs. annual screening for breast cancer. Journal of Clinical Oncology. 34: TPS1594-TPS1594. DOI: 10.1200/Jco.2016.34.15_Suppl.Tps1594 |
0.347 |
|
| 2016 |
Theiner S, Kaplan C, Sarrafan S, Cabrera J, Sawyer SD, Liang AS, Rosenberg-Wohl S, Frick M, Wong EC, Tice J, Ziv E, Borowsky AD, Anton-Culver H, Naeim A, LaCroix A, et al. The WISDOM study pilot: Evaluating a preference-tolerant RCT of risk-based vs. annual breast cancer screening. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E13035 |
0.351 |
|
| 2016 |
Esserman L, Thompson C, Yau C, Veer Lv', Borowsky A, Tobin N, Nordenskjöld B, Fornander T, Stål O, Benz C, Lindström L. Abstract P6-09-01: Identification of tumors with an indolent disease course: MammaPrint ultralow signature validation in a retrospective analysis of a Swedish randomized tamoxifen trial Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-09-01 |
0.405 |
|
| 2016 |
Narasimmaraj P, Fiscalini AS, Kaplan C, Veer Lv, Hallada A, Thompson C, Theiner S, Borowsky A, Naeim A, Anton-Culver H, LaCroix A, Esserman L. Abstract P3-10-01: A pilot feasibility study of the WISDOM study, a preference-tolerant randomized controlled trial evaluating a risk-based breast cancer screening strategy Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-10-01 |
0.358 |
|
| 2016 |
Silvestrini MT, Kheirolomoom A, Ingham ES, Mahakian LM, Tam SM, Foiret J, Tucci S, Hubbard NE, Borowsky AD, Ferrara KW. Abstract LB-052: Activatable nanodelivery combined with CpG-ODN and anti-PD-1 achieves a complete response in directly-treated and contralateral tumors in a murine breast cancer model Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-052 |
0.435 |
|
| 2015 |
Chang H, Zhou Y, Borowsky A, Barner K, Spellman P, Parvin B. Stacked Predictive Sparse Decomposition for Classification of Histology Sections. International Journal of Computer Vision. 113: 3-18. PMID 27721567 DOI: 10.1007/S11263-014-0790-9 |
0.308 |
|
| 2015 |
Hines WC, Kuhn I, Thi K, Chu B, Stanford-Moore G, Sampayo R, Garbe JC, Stampfer M, Borowsky AD, Bissell MJ. 184AA3: a xenograft model of ER(+) breast adenocarcinoma. Breast Cancer Research and Treatment. PMID 26661596 DOI: 10.1007/S10549-015-3649-Z |
0.46 |
|
| 2015 |
Wong AW, Fite BZ, Liu Y, Kheirolomoom A, Seo JW, Watson KD, Mahakian LM, Tam SM, Zhang H, Foiret J, Borowsky AD, Ferrara KW. Ultrasound ablation enhances drug accumulation and survival in mammary carcinoma models. The Journal of Clinical Investigation. PMID 26595815 DOI: 10.1172/Jci83312 |
0.387 |
|
| 2015 |
Kheirolomoom A, Ingham ES, Mahakian LM, Tam SM, Silvestrini MT, Tumbale SK, Foiret J, Hubbard NE, Borowsky AD, Murphy WJ, Ferrara KW. CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 220: 253-264. PMID 26471394 DOI: 10.1016/J.Jconrel.2015.10.016 |
0.373 |
|
| 2015 |
Engelberg JA, Retallack H, Balassanian R, Dowsett M, Zabaglo L, Ram AA, Apple SK, Bishop JW, Borowsky AD, Carpenter PM, Chen YY, Datnow B, Elson S, Hasteh F, Lin F, et al. "Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring. Human Pathology. PMID 26410019 DOI: 10.1016/J.Humpath.2015.07.008 |
0.354 |
|
| 2015 |
Rowson-Hodel AR, Manjarin R, Trott JF, Cardiff RD, Borowsky AD, Hovey RC. Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo. Bmc Cancer. 15: 562. PMID 26228788 DOI: 10.1186/S12885-015-1572-7 |
0.442 |
|
| 2015 |
Chen JQ, Mori H, Cardiff RD, Trott JF, Hovey RC, Hubbard NE, Engelberg JA, Tepper CG, Willis BJ, Khan IH, Ravindran RK, Chan SR, Schreiber RD, Borowsky AD. Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent. Plos One. 10: e0129895. PMID 26075897 DOI: 10.1371/Journal.Pone.0129895 |
0.326 |
|
| 2015 |
Zhang H, Tam S, Ingham ES, Mahakian LM, Lai CY, Tumbale SK, Teesalu T, Hubbard NE, Borowsky AD, Ferrara KW. Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble. Biomaterials. 56: 104-13. PMID 25934284 DOI: 10.1016/J.Biomaterials.2015.03.043 |
0.394 |
|
| 2015 |
Fite BZ, Wong A, Liu Y, Mahakian LM, Tam SM, Aina O, Hubbard NE, Borowsky A, Cardiff RD, Dumont E, Ferrara KW. Magnetic resonance imaging assessment of effective ablated volume following high intensity focused ultrasound. Plos One. 10: e0120037. PMID 25785992 DOI: 10.1371/Journal.Pone.0120037 |
0.324 |
|
| 2015 |
Mudryj M, Siddiqui S, Libertini SJ, Lombard AP, Mooso B, D'Abronzo L, Melgoza F, Borowsky A, Drake C, Qi L, Ghosh PM. Abstract 5051: Androgen receptor-mediated regulation of p14ARF transcription in prostate tumor cells Cancer Research. 75: 5051-5051. DOI: 10.1158/1538-7445.Am2015-5051 |
0.405 |
|
| 2015 |
Simion C, Chen QJ, Wilkerson CL, Rafidi H, Borowsky AD, Sweeney C. Abstract 32: The role of Lrig1 signaling in mammary gland development and tumorigenesis Cancer Research. 75: 32-32. DOI: 10.1158/1538-7445.Am2015-32 |
0.437 |
|
| 2015 |
Lindström LS, Yau C, Czene K, Thompson CK, Veer LJV, Nordenskjöld B, Stål O, Fornander T, Benz CC, Borowsky AD, Esserman LJ. 1812 Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival. Retrospective analyses of the STO3 randomizedtrial European Journal of Cancer. 51. DOI: 10.1016/S0959-8049(15)30036-8 |
0.398 |
|
| 2014 |
Candas D, Lu CL, Fan M, Chuang FY, Sweeney C, Borowsky AD, Li JJ. Mitochondrial MKP1 is a target for therapy-resistant HER2-positive breast cancer cells. Cancer Research. 74: 7498-509. PMID 25377473 DOI: 10.1158/0008-5472.Can-14-0844 |
0.447 |
|
| 2014 |
Veiseh M, Kwon DH, Borowsky AD, Tolg C, Leong HS, Lewis JD, Turley EA, Bissell MJ. Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset. Proceedings of the National Academy of Sciences of the United States of America. 111: E1731-9. PMID 24733940 DOI: 10.1073/Pnas.1402383111 |
0.42 |
|
| 2014 |
Angelo M, Bendall SC, Finck R, Hale MB, Hitzman C, Borowsky AD, Levenson RM, Lowe JB, Liu SD, Zhao S, Natkunam Y, Nolan GP. Multiplexed ion beam imaging of human breast tumors. Nature Medicine. 20: 436-42. PMID 24584119 DOI: 10.1038/Nm.3488 |
0.348 |
|
| 2014 |
Cardiff RD, Borowsky AD. At last: classification of human mammary cells elucidates breast cancer origins. The Journal of Clinical Investigation. 124: 478-80. PMID 24463442 DOI: 10.1172/Jci73910 |
0.444 |
|
| 2014 |
Grabowska MM, DeGraff DJ, Yu X, Jin RJ, Chen Z, Borowsky AD, Matusik RJ. Mouse models of prostate cancer: picking the best model for the question. Cancer Metastasis Reviews. 33: 377-97. PMID 24452759 DOI: 10.1007/S10555-013-9487-8 |
0.343 |
|
| 2014 |
Sun F, Chen HG, Li W, Yang X, Wang X, Jiang R, Guo Z, Chen H, Huang J, Borowsky AD, Qiu Y. Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors. The Journal of Biological Chemistry. 289: 1529-39. PMID 24297183 DOI: 10.1074/Jbc.M113.492140 |
0.308 |
|
| 2014 |
Candas D, Lu C, Fan M, Chuang F, Sweeney C, Borowsky A, Li JJ. Abstract 3029: MKP1-mediated survival of HER2 positive breast cancer stem cells Cancer Research. 74: 3029-3029. DOI: 10.1158/1538-7445.Am2014-3029 |
0.475 |
|
| 2014 |
Zou JX, Wang J, Duan Z, Chen H, Kung H, Chen X, Murphy LC, Borowsky A. Abstract 2433: Metabolic reprogramming by an epigenetic mechanism in endocrine therapy resistance of breast cancer Cancer Research. 74: 2433-2433. DOI: 10.1158/1538-7445.Am2014-2433 |
0.427 |
|
| 2013 |
Hubbard NE, Chen QJ, Sickafoose LK, Wood MB, Gregg JP, Abrahamsson NM, Engelberg JA, Walls JE, Borowsky AD. Transgenic mammary epithelial osteopontin (spp1) expression induces proliferation and alveologenesis. Genes & Cancer. 4: 201-12. PMID 24069507 DOI: 10.1177/1947601913496813 |
0.369 |
|
| 2013 |
Ittmann M, Huang J, Radaelli E, Martin P, Signoretti S, Sullivan R, Simons BW, Ward JM, Robinson BD, Chu GC, Loda M, Thomas G, Borowsky A, Cardiff RD. Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Research. 73: 2718-36. PMID 23610450 DOI: 10.1158/0008-5472.Can-12-4213 |
0.373 |
|
| 2013 |
Cardiff RD, Hubbard NE, Engelberg JA, Munn RJ, Miller CH, Walls JE, Chen JQ, Velásquez-García HA, Galvez JJ, Bell KJ, Beckett LA, Li YJ, Borowsky AD. Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancers. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 480-97. PMID 23399853 DOI: 10.1038/Labinvest.2013.10 |
0.453 |
|
| 2013 |
Buckle T, Kuil J, van den Berg NS, Bunschoten A, Lamb HJ, Yuan H, Josephson L, Jonkers J, Borowsky AD, van Leeuwen FW. Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS. Plos One. 8: e48324. PMID 23326303 DOI: 10.1371/Journal.Pone.0048324 |
0.33 |
|
| 2013 |
Chang H, Han J, Borowsky A, Loss L, Gray JW, Spellman PT, Parvin B. Invariant delineation of nuclear architecture in glioblastoma multiforme for clinical and molecular association. Ieee Transactions On Medical Imaging. 32: 670-82. PMID 23221815 DOI: 10.1109/Tmi.2012.2231420 |
0.359 |
|
| 2013 |
Duan Z, Zou JX, Yang P, Wang Y, Borowsky AD, Gao AC, Chen HW. Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex. The Prostate. 73: 455-66. PMID 23038103 DOI: 10.1002/Pros.22587 |
0.307 |
|
| 2013 |
Candas D, Chuang F, Fan M, Shen R, Sweeney C, Borowsky A, Vaughan A, Li JJ. Abstract 74: Mitochondrial MKP1-mediated radioresistance in breast cancer stem cells. Cancer Research. 73: 74-74. DOI: 10.1158/1538-7445.Am2013-74 |
0.46 |
|
| 2012 |
Engelberg J, Apple S, Balassanian R, Borowsky AD, Cardiff RD, Carpenter PM, Chen YY, Datnow B, Elson S, Hasteh F, Lin F, Moatamed NA, Perkovich B, Zhang Y. Raising the bar: Breast cancer biomarkers IHC4 harmonization from University of California-Athena pathology collaboration. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 80. PMID 28147044 DOI: 10.1200/Jco.2012.30.34_Suppl.80 |
0.389 |
|
| 2012 |
D'Amato NC, Ostrander JH, Bowie ML, Sistrunk C, Borowsky A, Cardiff RD, Bell K, Young LJ, Simin K, Bachelder RE, Delrow J, Dawson A, Yee LD, Mrózek K, Clay TM, et al. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. Plos One. 7: e45684. PMID 23049838 DOI: 10.1371/Journal.Pone.0045684 |
0.469 |
|
| 2012 |
Borowsky AD, Bandhuvula P, Kumar A, Yoshinaga Y, Nefedov M, Fong LG, Zhang M, Baridon B, Dillard L, de Jong P, Young SG, West DB, Saba JD. Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues. Journal of Lipid Research. 53: 1920-31. PMID 22781001 DOI: 10.1194/Jlr.M028084 |
0.317 |
|
| 2012 |
Boucher DL, Chen JQ, Cherry SR, Borowsky AD. Establishment of clonal MIN-O transplant lines for molecular imaging via lentiviral transduction & in vitro culture. Plos One. 7: e39350. PMID 22745739 DOI: 10.1371/Journal.Pone.0039350 |
0.334 |
|
| 2012 |
Vinall RL, Chen JQ, Hubbard NE, Sulaimon SS, Shen MM, Devere White RW, Borowsky AD. Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression. Disease Models & Mechanisms. 5: 914-20. PMID 22563073 DOI: 10.1242/Dmm.008995 |
0.339 |
|
| 2012 |
Garbe JC, Pepin F, Pelissier FA, Sputova K, Fridriksdottir AJ, Guo DE, Villadsen R, Park M, Petersen OW, Borowsky AD, Stampfer MR, Labarge MA. Accumulation of multipotent progenitors with a basal differentiation bias during aging of human mammary epithelia. Cancer Research. 72: 3687-701. PMID 22552289 DOI: 10.1158/0008-5472.Can-12-0157 |
0.406 |
|
| 2012 |
Dusek RL, Bascom JL, Vogel H, Baron S, Borowsky AD, Bissell MJ, Attardi LD. Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer. Breast Cancer Research : Bcr. 14: R65. PMID 22515648 DOI: 10.1186/Bcr3171 |
0.482 |
|
| 2012 |
Veiseh M, Kwon D, Borowsky A, Toelg C, Leong H, Lewis J, Turley E, Bissell M. Abstract P1-05-20: Fluorescent Hyaluronan Probes Distinguish Heterogeneous Breast Cancer Cell Subsets and Predict their Invasive Behavior Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-05-20 |
0.426 |
|
| 2011 |
Borowsky AD. Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer. Cold Spring Harbor Perspectives in Biology. 3: a009670. PMID 21646376 DOI: 10.1101/Cshperspect.A009670 |
0.436 |
|
| 2011 |
Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, Geyer FC, Reis-Filho JS, Mao JH, Ravani SA, Zavadil J, Borowsky AD, Jerry DJ, Dunphy KA, Seo JH, Haslam S, Medina D, Barcellos-Hoff MH. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell. 19: 640-51. PMID 21575864 DOI: 10.1016/J.Ccr.2011.03.011 |
0.447 |
|
| 2011 |
Rygh CB, Qin S, Seo JW, Mahakian LM, Zhang H, Adamson R, Chen JQ, Borowsky AD, Cardiff RD, Reed RK, Curry FR, Ferrara KW. Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 550-9. PMID 21106723 DOI: 10.1158/1078-0432.Ccr-10-2049 |
0.353 |
|
| 2011 |
de Leoz ML, Young LJ, An HJ, Kronewitter SR, Kim J, Miyamoto S, Borowsky AD, Chew HK, Lebrilla CB. High-mannose glycans are elevated during breast cancer progression. Molecular & Cellular Proteomics : McP. 10: M110.002717. PMID 21097542 DOI: 10.1074/Mcp.M110.002717 |
0.45 |
|
| 2011 |
Fujita M, Ieguchi K, Cardiff R, Borowsky AD, Takada Y. Abstract LB-5: The dominant-negative effect of an insulin-like growth factor-1 mutant that is defective in binding to integrins (αvβ3 and α6β4) Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-5 |
0.31 |
|
| 2010 |
Kheirolomoom A, Mahakian LM, Lai CY, Lindfors HA, Seo JW, Paoli EE, Watson KD, Haynam EM, Ingham ES, Xing L, Cheng RH, Borowsky AD, Cardiff RD, Ferrara KW. Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. Molecular Pharmaceutics. 7: 1948-58. PMID 20925429 DOI: 10.1021/Mp100245U |
0.307 |
|
| 2010 |
Kalashnikova EV, Revenko AS, Gemo AT, Andrews NP, Tepper CG, Zou JX, Cardiff RD, Borowsky AD, Chen HW. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Research. 70: 9402-12. PMID 20864510 DOI: 10.1158/0008-5472.Can-10-1199 |
0.479 |
|
| 2010 |
Nair R, Junankar S, O'Toole S, Shah J, Borowsky AD, Bishop JM, Swarbrick A. Redefining the expression and function of the inhibitor of differentiation 1 in mammary gland development. Plos One. 5: e11947. PMID 20689821 DOI: 10.1371/Journal.Pone.0011947 |
0.408 |
|
| 2010 |
Ingalla EQ, Miller JK, Wald JH, Workman HC, Kaur RP, Yen L, Fry WH, Borowsky AD, Young LJ, Sweeney C, Carraway KL. Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors. The Journal of Biological Chemistry. 285: 28691-7. PMID 20628057 DOI: 10.1074/Jbc.M110.127977 |
0.424 |
|
| 2010 |
Flowers M, Schroeder JA, Borowsky AD, Besselsen DG, Thomson CA, Pandey R, Thompson PA. Pilot study on the effects of dietary conjugated linoleic acid on tumorigenesis and gene expression in PyMT transgenic mice. Carcinogenesis. 31: 1642-9. PMID 20624750 DOI: 10.1093/Carcin/Bgq148 |
0.409 |
|
| 2010 |
Qi J, Nakayama K, Cardiff RD, Borowsky AD, Kaul K, Williams R, Krajewski S, Mercola D, Carpenter PM, Bowtell D, Ronai ZA. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell. 18: 23-38. PMID 20609350 DOI: 10.1016/J.Ccr.2010.05.024 |
0.35 |
|
| 2010 |
Hsia EY, Kalashnikova EV, Revenko AS, Zou JX, Borowsky AD, Chen HW. Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer. Molecular Cancer Research : McR. 8: 183-93. PMID 20124470 DOI: 10.1158/1541-7786.Mcr-09-0095 |
0.426 |
|
| 2010 |
Cardiff RD, Borowsky AD. Precancer: sequentially acquired or predetermined? Toxicologic Pathology. 38: 171-9. PMID 20019354 DOI: 10.1177/0192623309356447 |
0.398 |
|
| 2010 |
Kheirolomoom A, Mahakian L, Lai C, Lindfors H, Seo JW, Watson KE, Haynam E, Ingham E, Xing L, Borowsky AD, Cardiff RD, Ferrara KW. Abstract 5538: Enhanced tumor cytotoxicity of a combinational therapy using liposomal copper-doxorubicin, rapamycin, and ultrasound Cancer Research. 70: 5538-5538. DOI: 10.1158/1538-7445.Am10-5538 |
0.335 |
|
| 2009 |
Workman HC, Miller JK, Ingalla EQ, Kaur RP, Yamamoto DI, Beckett LA, Young LJ, Cardiff RD, Borowsky AD, Carraway KL, Sweeney C, Carraway KL. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells. Breast Cancer Research : Bcr. 11: R70. PMID 19761616 DOI: 10.1186/Bcr2364 |
0.465 |
|
| 2009 |
Bowen SL, Wu Y, Chaudhari AJ, Fu L, Packard NJ, Burkett GW, Yang K, Lindfors KK, Shelton DK, Hagge R, Borowsky AD, Martinez SR, Qi J, Boone JM, Cherry SR, et al. Initial characterization of a dedicated breast PET/CT scanner during human imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1401-8. PMID 19690029 DOI: 10.2967/Jnumed.109.064428 |
0.312 |
|
| 2009 |
Perroud B, Ishimaru T, Borowsky AD, Weiss RH. Grade-dependent proteomics characterization of kidney cancer. Molecular & Cellular Proteomics : McP. 8: 971-85. PMID 19164279 DOI: 10.1074/Mcp.M800252-Mcp200 |
0.33 |
|
| 2009 |
Yang JC, Ok JH, Busby JE, Borowsky AD, Kung HJ, Evans CP. Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer. Cancer Research. 69: 151-60. PMID 19117998 DOI: 10.1158/0008-5472.Can-08-0442 |
0.377 |
|
| 2008 |
Miller JK, Shattuck DL, Ingalla EQ, Yen L, Borowsky AD, Young LJ, Cardiff RD, Carraway KL, Sweeney C. Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer. Cancer Research. 68: 8286-94. PMID 18922900 DOI: 10.1158/0008-5472.Can-07-6316 |
0.468 |
|
| 2008 |
Miller JW, Borowsky AD, Marple TC, McGoldrick ET, Dillard-Telm L, Young LJ, Green R. Folate, DNA methylation, and mouse models of breast tumorigenesis. Nutrition Reviews. 66: S59-64. PMID 18673493 DOI: 10.1111/J.1753-4887.2008.00070.X |
0.342 |
|
| 2008 |
Damonte P, Hodgson JG, Chen JQ, Young LJ, Cardiff RD, Borowsky AD. Mammary carcinoma behavior is programmed in the precancer stem cell. Breast Cancer Research : Bcr. 10: R50. PMID 18522749 DOI: 10.1186/Bcr2104 |
0.388 |
|
| 2008 |
Rizki A, Weaver VM, Lee SY, Rozenberg GI, Chin K, Myers CA, Bascom JL, Mott JD, Semeiks JR, Grate LR, Mian IS, Borowsky AD, Jensen RA, Idowu MO, Chen F, et al. A human breast cell model of preinvasive to invasive transition. Cancer Research. 68: 1378-87. PMID 18316601 DOI: 10.1158/0008-5472.Can-07-2225 |
0.43 |
|
| 2007 |
Borowsky AD. Special considerations in mouse models of breast cancer. Breast Disease. 28: 29-38. PMID 18057541 DOI: 10.3233/Bd-2007-28104 |
0.486 |
|
| 2007 |
Damonte P, Gregg JP, Borowsky AD, Keister BA, Cardiff RD. EMT tumorigenesis in the mouse mammary gland. Laboratory Investigation; a Journal of Technical Methods and Pathology. 87: 1218-26. PMID 17922020 DOI: 10.1038/Labinvest.3700683 |
0.457 |
|
| 2007 |
Weiss RH, Borowsky AD, Seligson D, Lin PY, Dillard-Telm L, Belldegrun AS, Figlin RA, Pantuck AD. p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches. The Journal of Urology. 177: 63-8; discussion 68-. PMID 17162001 DOI: 10.1016/J.Juro.2006.08.073 |
0.369 |
|
| 2007 |
Kirmiz C, Li B, An HJ, Clowers BH, Chew HK, Lam KS, Ferrige A, Alecio R, Borowsky AD, Sulaimon S, Lebrilla CB, Miyamoto S. A serum glycomics approach to breast cancer biomarkers. Molecular & Cellular Proteomics : McP. 6: 43-55. PMID 16847285 DOI: 10.1074/Mcp.M600171-Mcp200 |
0.454 |
|
| 2006 |
Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP. Heterogeneity of mammary lesions represent molecular differences. Bmc Cancer. 6: 275. PMID 17147824 DOI: 10.1186/1471-2407-6-275 |
0.32 |
|
| 2006 |
Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. Cancer Research. 66: 11279-86. PMID 17145873 DOI: 10.1158/0008-5472.Can-06-2319 |
0.481 |
|
| 2006 |
Abbey CK, Borowsky AD, Gregg JP, Cardiff RD, Cherry SR. Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography. Journal of Mammary Gland Biology and Neoplasia. 11: 137-49. PMID 17091397 DOI: 10.1007/S10911-006-9020-6 |
0.305 |
|
| 2006 |
Oskouian B, Sooriyakumaran P, Borowsky AD, Crans A, Dillard-Telm L, Tam YY, Bandhuvula P, Saba JD. Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proceedings of the National Academy of Sciences of the United States of America. 103: 17384-9. PMID 17090686 DOI: 10.1073/Pnas.0600050103 |
0.334 |
|
| 2006 |
Cardiff RD, Gregg JP, Miller JW, Axelrod DE, Borowsky AD. Histopathology as a predictive biomarker: strengths and limitations. The Journal of Nutrition. 136: 2673S-5S. PMID 16988145 DOI: 10.1093/Jn/136.10.2673S |
0.442 |
|
| 2006 |
Dai B, Kim O, Xie Y, Guo Z, Xu K, Wang B, Kong X, Melamed J, Chen H, Bieberich CJ, Borowsky AD, Kung HJ, Wei G, Ostrowski MC, Brodie A, et al. Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse. Cancer Research. 66: 8058-64. PMID 16912182 DOI: 10.1158/0008-5472.Can-06-1364 |
0.328 |
|
| 2006 |
Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 2613-21. PMID 16638874 DOI: 10.1158/1078-0432.Ccr-05-2170 |
0.421 |
|
| 2005 |
Namba R, Young LJ, Maglione JE, McGoldrick ET, Liu S, Wurz GT, DeGregorio MW, Borowsky AD, MacLeod CL, Cardiff RD, Gregg JP. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ. Breast Cancer Research : Bcr. 7: R881-9. PMID 16280035 DOI: 10.1186/Bcr1317 |
0.397 |
|
| 2005 |
Chao RC, Pyzel U, Fridlyand J, Kuo YM, Teel L, Haaga J, Borowsky A, Horvai A, Kogan SC, Bonifas J, Huey B, Jacks TE, Albertson DG, Shannon KM. Therapy-induced malignant neoplasms in Nf1 mutant mice. Cancer Cell. 8: 337-48. PMID 16226708 DOI: 10.1016/J.Ccr.2005.08.011 |
0.418 |
|
| 2005 |
Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, McGoldrick ET, Muller WJ, Cardiff RD, Gregg JP. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clinical & Experimental Metastasis. 22: 47-59. PMID 16132578 DOI: 10.1007/S10585-005-2908-5 |
0.339 |
|
| 2004 |
Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M, Lee H, Shih WJ, Cardiff RD, Shen MM, Abate-Shen C. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 101: 17204-9. PMID 15569926 DOI: 10.1073/Pnas.0407693101 |
0.328 |
|
| 2004 |
Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Felsher DW. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 431: 1112-7. PMID 15475948 DOI: 10.1038/Nature03043 |
0.359 |
|
| 2004 |
Gum JR, Hicks JW, Crawley SC, Yang SC, Borowsky AD, Dahl CM, Kakar S, Kim DH, Cardiff RD, Kim YS. Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colon. Molecular Cancer Research : McR. 2: 504-13. PMID 15383629 |
0.318 |
|
| 2004 |
Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, Moghanaki D, Ellies LG, Borowsky AD, Cardiff RD, MacLeod CL. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Molecular Cancer Therapeutics. 3: 941-53. PMID 15299077 |
0.348 |
|
| 2004 |
Abbey CK, Borowsky AD, McGoldrick ET, Gregg JP, Maglione JE, Cardiff RD, Cherry SR. In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. Proceedings of the National Academy of Sciences of the United States of America. 101: 11438-43. PMID 15277673 DOI: 10.1073/Pnas.0404396101 |
0.387 |
|
| 2004 |
Cardiff RD, Rosner A, Hogarth MA, Galvez JJ, Borowsky AD, Gregg JP. Validation: the new challenge for pathology. Toxicologic Pathology. 32: 31-9. PMID 15209401 DOI: 10.1080/01926230490424662 |
0.467 |
|
| 2004 |
Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G, Schmale MC, MacCollin M, Chao RC, Cichowski K, Kalamarides M, et al. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Research. 64: 3718-24. PMID 15150133 DOI: 10.1158/0008-5472.Can-03-4079 |
0.319 |
|
| 2004 |
Jessen KA, Liu SY, Tepper CG, Karrim J, McGoldrick ET, Rosner A, Munn RJ, Young LJ, Borowsky AD, Cardiff RD, Gregg JP. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Research : Bcr. 6: R157-69. PMID 15084239 DOI: 10.1186/Bcr768 |
0.352 |
|
| 2004 |
Dong Y, Chi SL, Borowsky AD, Fan Y, Weiss RH. Cytosolic p21Waf1/Cip1 increases cell cycle transit in vascular smooth muscle cells. Cellular Signalling. 16: 263-9. PMID 14636896 DOI: 10.1016/S0898-6568(03)00136-0 |
0.301 |
|
| 2003 |
McDaniel LD, Chester N, Watson M, Borowsky AD, Leder P, Schultz RA. Chromosome instability and tumor predisposition inversely correlate with BLM protein levels. Dna Repair. 2: 1387-404. PMID 14642567 DOI: 10.1016/J.Dnarep.2003.08.006 |
0.353 |
|
| 2003 |
Fan Y, Borowsky AD, Weiss RH. An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells. Molecular Cancer Therapeutics. 2: 773-82. PMID 12939467 |
0.318 |
|
| 2003 |
Borowsky A. Mammary intraepithelial neoplasia outgrowths (MINO): MINO and human ductal carcinoma in situ Breast Cancer Research. 5: 45-45. DOI: 10.1186/Bcr704 |
0.372 |
|
| 2003 |
Namba L, Liu S, McGoldrick E, Young L, Borowsky A, Cardiff R, Gregg J. The molecular biology of mammary intraepithelial neoplasia outgrowths Breast Cancer Research. 5: 23-23. DOI: 10.1186/Bcr682 |
0.45 |
|
| 2003 |
Borowsky A. Mammary pathology of the genetically engineered mouse Breast Cancer Research. 5: 11-11. DOI: 10.1186/Bcr670 |
0.488 |
|
| 1996 |
Meyerowitz CB, Fleischer AC, Pickens DR, Thurman GB, Borowsky AD, Thirsk G, Hellerqvist CG. Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: preliminary results. Journal of Ultrasound in Medicine. 15: 827-833. PMID 8947858 DOI: 10.7863/Jum.1996.15.12.827 |
0.32 |
|
| Show low-probability matches. |